{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"description":"This endpoint was to study safety and tolerability of HSC835 as measured by the absence of graft failure at day 42 in excess of that currently observed with double umbilical cord blood (UCB) transplantation (DUCBT) with non-myeloablative (NMA) conditioning.","groups":[{"description":"Patients with hematologic malignancies requiring UCB transplant with a NMA conditioning regimen.","id":"OG000","title":"HSC835"}],"paramType":"NUMBER","populationDescription":"Safety Analysis Set: The Safety analysis included all enrolled patients who were transplanted with HSC835 (any patient with a date for HSC835 transplant).","reportingStatus":"POSTED","timeFrame":"42 days","title":"Absence of Graft Failure at Day 42","type":"PRIMARY","unitOfMeasure":"Participants"}